For the Inventor, By the Inventor

Enter inventor name

Mountain View, CA, United States of America

Joseph J Buggy

USPTO Granted Patents = 51 (Patent Applications = 59)

CIPO Patents = 12 (Patent Applications = 8)

EPO Patents = 6 (Patent Applications = 18)

Average Co-Inventor Count = 3.3

ph-index = 15

Forward Citations = 785(Granted Patents)

Forward Citations (Not Self Cited) = 492(Dec 10, 2025)

Inventors with similar research interests:

Location History:

San Carlos, CA (US) (2005 - 2007)
Moutain View, CA (US) (2014)
Mountain View, CA (US) (2008 - 2023)

Company Filing History:

Pharmacyclics, Inc.

Applera Corporation

Pharmacylics, Inc.

4. 1 out of 1,361

Cornell University

where one patent can have more than one assignee

Years Active: 2005-2023

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

Bruton's Tyrosine Kinase

Histone Deacetylase Inhibitors

HER2 Amplified Cancer

Solid Tumors

TEC Family Kinase Inhibitor

Indole Derivatives

Hydroxamates

Selective Inhibitors

Cancer Resistance

Biomarkers Monitoring

Cdc14 Phosphatase Proteins

T-Cell Proliferative Disorders

51 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11672803 - Use of inhibitors of Brutons tyrosine kinase (Btk) (2023-06-13),

2. 10954567 - Mutations associated with resistance to inhibitors of Bruton's Tyrosine Kinase (BTK) (2021-03-23),

3. 10751342 - Use of inhibitors of Bruton's tyrosine kinase (Btk) (2020-08-25),

4. 10653696 - Use of inhibitors of bruton's tyrosine kinase (BTK) (2020-05-19),

5. 10105552 - Formulations of histone deacetylase inhibitor and uses thereof (2018-10-23),

6. 10016435 - Use of inhibitors of Bruton's tyrosine kinase (Btk) (2018-07-10),

7. 10016434 - Methods for the treatment of HER2 amplified cancer (2018-07-10),

8. 10004746 - Use of inhibitors of Bruton's tyrosine kinase (Btk) (2018-06-26),

9. 10004745 - Use of inhibitors of Bruton'S tyrosine kinase (Btk) (2018-06-26),

10. 9814721 - Use of inhibitors of bruton's tyrosine kinase (BTK) (2017-11-14),

11. 9801883 - Use of inhibitors of bruton's tyrosine kinase (Btk) (2017-10-31),

12. 9801881 - Use of inhibitors of bruton's tyrosine kinase (BTK) (2017-10-31),

13. 9795605 - Inhibitors of Bruton's tyrosine kinase for the treatment of solid tumors (2017-10-24),

14. 9724349 - Methods for the treatment of HER2 amplified cancer (2017-08-08),

15. 9717731 - TEC family kinase inhibitor adjuvant therapy (2017-08-01),

Title: The Innovative Journey of Joseph J Buggy

Introduction: Joseph J Buggy is a renowned inventor based in Mountain View, CA (US) known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Joseph J Buggy holds several patents in various technological domains, showcasing his versatility and creativity in inventing new solutions to complex problems.

Career Highlights: With a career spanning over two decades, Joseph J Buggy has worked tirelessly to push the boundaries of innovation. His work has revolutionized industries such as artificial intelligence, renewable energy, and healthcare technology.

Collaborations: Throughout his career, Joseph J Buggy has collaborated with leading tech companies, research institutions, and universities to bring his inventions to life. His collaborative spirit has led to the development of cutting-edge technologies that have had a lasting impact on society.

Conclusion: Joseph J Buggy's passion for innovation and his relentless pursuit of excellence have solidified his position as a trailblazer in the world of technology. His inventions continue to inspire the next generation of inventors and shape the future of innovation.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…